Popular Manga Dandadan Takes Over Ikebukuro with First Art Exhibition
Fans of Yukinobu Tatsu's genre-bending manga Dandadan have something special to celebrate this summer. From June 20 to July 6, the very first Dandadan original art exhibition, titled Dandadan Gengaten , is being held at Sunshine City Exhibition Hall A in Ikebukuro, Tokyo.
With the anime's second season set to premiere on July 3, this exhibition is a perfect opportunity to dive deep into the occult-infused world of Dandadan and experience the story's pulse-pounding intensity and emotional depth in person.
Structured across six immersive zones, Dandadan Gengaten is a full-fledged journey through the wild, the weird, and the wonderful universe Tatsu has created.
Visitors are first greeted with a high-energy opening movie, bringing key moments from the manga to life on screen with rapid pacing and an electrifying soundtrack. This sets the tone for what's to come: a sensory, full-body plunge into the chaos and charm of Dandadan . Character Introduction chapter (courtesy of Dandadan Gengaten Public Relations Office)
The first chapter, Character Introduction, introduces the manga's unforgettable cast through a gallery of iconic scenes and life-size visuals. From high schooler and spirit-sensitive heroine Momo to her classmate and UFO-believer Okarun, and quirky supporting characters like Seiko, Aira, and Jiji, this section celebrates the eclectic personalities that drive the story. Notably, Seiko's iconic metal bat Nessie also makes an appearance.
Next, Occult dives into the bizarre supernatural creatures that populate the Dandadan universe. Here you'll find display panels and descriptions of everything from the infamous Turbo Granny to the eerie Reiko Kashima, complete with a UFO abduction panel and a glass-encased replica of Evil Eye's notorious briefs.
The third chapter, Making of Dandadan, offers a rare peek into Tatsu's creative process. Original manuscripts from the first three chapters are on display, accompanied by production notes and early sketches. Visitors can also enjoy illustrations from the manga's first popularity poll, each with handwritten commentary from Tatsu himself.
Occultic Battle, the fourth chapter, is a feast for action lovers. Walls are lined with dynamic two-page battle spreads, while raw manuscripts of Momo and Okarun's fiercest fights highlight the intensity and visual ingenuity of the series. This area is a no-photo zone, meaning fans must see the high-impact pages with their own eyes. A pair of life-sized statues of the main characters makes for a dramatic centerpiece. Panel from the Love Comedy chapter (courtesy of Dandadan Gengaten Public Relations Office)
The fifth chapter, Love Comedy, highlights Dandadan 's often-overlooked romantic heart. This section is filled with heartwarming, sometimes hilarious moments of young love, with a mini-theater screening the bonus story featuring Turbo Granny and Seiko from the manga volumes' end pages.
Finally, Emotion brings it all home. Key scenes are chosen to showcase the emotional resonance of Dandadan . For example, Acrobatic Silky's soul passing on after being embraced by Aira, and the tearful farewell between Bamora and Banga. These panels remind us that beneath all the ghosts, aliens, and absurdity, Dandadan is ultimately a story about connection, courage, and growing up.
Dandadan Gengaten also goes beyond the manga pages with interactive photo spots, exclusive merchandise, and immersive audio-visual experiences. Specially designed merchandise includes t-shirts printed with famous quotes, stylish acrylic dioramas, and multi-use pouches that blend design and function. These items are ideal for fans who want to take a piece of Dandadan into their daily lives.
Detailed explanations of characters, episodes, and settings ensure even first-time visitors can enjoy the world on display. Dandadan Gengaten exclusive merchandise (courtesy of Dandadan Gengaten Public Relations Office)
Following the Tokyo run, Dandadan Gengaten will travel to Hiroshima (October 2025), Fukuoka (December 2025), and Osaka (February 2026). Tickets are available online and at the venue, with options ranging from general admission (¥2,000 JPY/$13 USD at the door) to special ticket bundles that include exclusive merchandise.
Whether you're a diehard fan or new to the world of Momo and Okarun, Dandadan Gengaten offers a thrilling, funny, and deeply heartfelt experience that captures the full spectrum of Yukinobu Tatsu's breakout hit.
Dates: June 20 – July 6, 2025
Venue: Sunshine City Exhibition Hall A, Ikebukuro, Tokyo
Hours: 10:00–19:00 (last entry 18:30)
Tickets: General (¥2,000/$13), Child (¥1,500/$10), Special Ticket w/gift (¥4,000/$26)
Author: Daniel Manning
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
South Wales Argus
27 minutes ago
- South Wales Argus
Rogerstone: Four-bed detached house in Alcan Grove for sale
The property, listed by Davis & Sons, boasts a large living room, study, utility room, conservatory, and a spacious kitchen diner. There is also an en-suite attached to the master bedroom, and another to the second bedroom. The property also features an entrance hall, utility room, and a downstairs WC. The conservatory (Image: Davis & Sons) The property has a large evergreen rear garden, a spacious lawn area, and a patio seating area. There is also a double driveway and garage to the front, providing ample off-street parking. The house is situated in a quiet residential area, close to local amenities, schools, and transport links. Rogerstone, a suburban village in Newport, blends historic charm with modern convenience. One of the bedrooms (Image: Davis & Sons) It offers well-regarded schools, green spaces like the Fourteen Locks Canal Centre, and regular rail links to Newport and Cardiff via Rogerstone station. With easy access to the M4, it is a popular choice for families and commuters seeking a strong community feel with excellent transport connections. The agency states: "This property is not to be missed." To arrange a viewing, contact the Newport head office or reach out via email.
Yahoo
28 minutes ago
- Yahoo
Alex Pereira: Focus on Magomed Ankalaev rematch, not heavyweight move
NEW YORK—Fans clamoring for Alex Pereira to move to heavyweight are going to have to wait a bit longer. Pereira dropped the UFC light heavyweight title to Magomed Ankalaev in the main event of UFC 313 in March. With the heavyweight division up in the air, Jon Jones saying multiple times he's not interested in fighting right now, and interim champ Tom Aspinall looking for an opponent, 'Poatan' would be a popular choice to flip one of the UFC's thinner divisions upside down. Advertisement That time is not now, however, as Pereira has his sights set on a fall return to avenge his loss to Ankalaev. 'Anywhere around the timeframe [of] September, October, November, for me it makes no difference, I want to fight,' Pereira told MMA Fighting at Fanatics Fest. 'My focus right now is fighting Ankalaev... get my belt back, and then we see what happens after.' Pereira has accomplished so much in so little time that the opportunity to win a third divisional title seems like a reasonable goal and request. Right now, Pereira hopes the heavyweight division can get moving again in an entertaining way, but he has his own boxes to check. Advertisement 'Let those guys kill each other in that weight class,' Pereira said. 'Right now I'm just focusing on light heavyweight.' More from
The Independent
28 minutes ago
- The Independent
Weight loss pill shows promise in new trial
A new weight loss medication, which can be offered by injection or tablet, can help patients lose a significant amount weight, studies suggest. An early study have found that people who received higher doses of amycretin as a weekly jab lost 24.3% of their body weight after 36 weeks of treatment. And initial trials assessing a tablet form of the drug also showed promising results, with patients taking daily tablets losing an average of 13.1% of their body weight after 12 weeks. Weight loss jabs have been hailed as transformative by NHS leaders. But injections come with additional work for over-stretched health services so tablet forms of medication may offer a new hope for the millions of people looking to lose weight. It has been estimated that around 1.5 million Britons are having weight loss jabs, which have been either prescribed through specialist weight loss services or private prescriptions. GPs will be able to dish out that jabs from next week. Amycretin, made by Novo Nordisk, helps to control blood sugar and appetite by targeting two specific receptors in the body – GLP-1 and the amylin receptor. An early trial in 125 adults testing weekly injections of amycretin, which has been published in The Lancet, found that those taking the highest dosage (60mg) lost 24.3% after 36 weeks of treatment. It also showed signs in improving blood sugar levels. Side effects included nausea and vomiting and were mostly mild to moderate and resolved by the end of treatment. 'These phase 1b/2a data support the potential of once-weekly subcutaneous amycretin as a therapeutic for people living with overweight or obesity,' the authors wrote. 'Amycretin appeared safe and tolerable, and there were significant reductions in body weight after 36 weeks of treatment.' The second early trial, published in the same journal, assessed amycretin in tablet form in 144 people over 12 weeks. There were mild to moderate side effects including loss of appetite, nausea and vomiting. Researchers found that people taking the highest dose of 100mg per day, lost 13.1% of their body weight over four months. The authors wrote: 'Amycretin effectively lowered body weight and improved metabolic and glycaemic parameters in people with overweight or obesity. 'Longer studies with more participants are warranted for evaluation of the safety and efficacy of amycretin in individuals living with obesity and type 2 diabetes, and to optimise the dosing regimen.' The studies were also presented at the American Diabetes Association's Scientific Sessions in Chicago, in the US. It comes as a separate study, which was published at the same meeting, examined the effects of weight loss jab Wegovy at higher doses. Researchers found that giving patients 7.2mg of Wegovy, also known as semaglutide, once a week led to an average weight loss of 20.7%, with a third of participants losing 25% or more of their body weight after 72 weeks.
